Elsabeh Rami, Singh Sukhbir, Shasho Jeff, Saltzman Yoni, Abrahams John M
Brain and Spine Surgeons of New York, White Plains, NY, USA.
Honeybee Robotics, Brooklyn, NY, USA.
Br J Neurosurg. 2021 Oct;35(5):532-540. doi: 10.1080/02688697.2021.1950622. Epub 2021 Aug 6.
The purpose of this review is to highlight the major factors limiting the progress of robotics development in the field of cranial neurosurgery.
A literature search was performed focused on published reports of any Neurosurgical technology developed for use in cranial neurosurgery. Technology was reviewed and assessed for strengths and weaknesses, use in patients and whether or not the project was active or closed.
Published reports of 24 robots are discussed going back to 1985. In total, there were 9 robots used in patients (PUMA, Robot Hand, EXPERT, Neuromate, Evolution 1, ROSA, iSYS1, NeuroArm and NeuRobot) and only 2 active today (ROSA, NeuroArm). Of all clinically active systems, only three were used in more than 30 patients (ROSA, iSYS1 & NeuroArm). Projects were limited by cost, technology adoption, and clinical utility to actually improve workflow. The most common use of developed robots is for Stereotaxis.
There is a clear void in the area of cranial neurosurgery regarding robotics technology despite success in other fields of surgery. Significant factors such as cost, technology limitations, market size and regulatory pathway all contribute to a steep gradient for success.
本综述的目的是突出限制颅神经外科领域机器人技术发展进程的主要因素。
进行了一项文献检索，重点关注已发表的任何用于颅神经外科的神经外科技术报告。对技术进行了审查和评估，分析其优缺点、在患者中的应用情况以及项目是处于活跃状态还是已结束。
讨论了自1985年以来24种机器人的已发表报告。总共有9种机器人应用于患者（PUMA、机器人手、EXPERT、Neuromate、Evolution 1、ROSA、iSYS1、NeuroArm和NeuRobot），目前只有2种仍在使用（ROSA、NeuroArm）。在所有临床应用的系统中，只有三种应用于超过30例患者（ROSA、iSYS1和NeuroArm）。项目受到成本、技术采用以及实际改善工作流程的临床实用性的限制。已开发机器人最常见的用途是立体定向。
尽管机器人技术在其他外科领域取得了成功，但在颅神经外科领域仍存在明显空白。成本、技术限制、市场规模和监管途径等重要因素都导致了成功的巨大梯度。
